Effects of magnesium sulphate on the pharmacodynamics of rocuronium in patients aged 60 years and older: A randomised trial

dc.contributor.authorRotava, Pedro
dc.contributor.authorCavalcanti, Ismar L.
dc.contributor.authorBarrucand, Louis
dc.contributor.authorVane, Luiz Antonio [UNESP]
dc.contributor.authorVerçosa, Nubia
dc.contributor.institutionUniversidade Federal do Rio de Janeiro (UFRJ)
dc.contributor.institutionUniversidade Federal Fluminense (UFF)
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2014-05-27T11:30:48Z
dc.date.available2014-05-27T11:30:48Z
dc.date.issued2013-10-01
dc.description.abstractBACKGROUND There is little information on the interaction between magnesium sulphate (MgSO4) and rocuronium in elderly patients. With a growing number of older patients who need surgical procedures, it is increasingly important to study this age group. OBJECTIVE To evaluate the effects of MgSO4 administration on the pharmacodynamics of rocuronium in patients aged 60 years or older. DESIGN A randomised controlled trial. SETTING A tertiary care hospital. PATIENTS Sixty-four patients, aged 60 years or older, American Society of Anesthesiologists (ASA) physical status classes I to III, scheduled for elective oncological head and neck surgery. Exclusion criteria were severe renal insufficiency (calculated creatinine clearance <30 ml min-1), preoperatorive serum magnesium concentration of more than 1.25 mmol l1 and patients receiving drugs known to affect neuromuscular function. INTERVENTIONS Patients were randomly allocated to one of two groups: in the magnesium group, patients received MgSO4 30mgkg1 intravenously, for 10 min, and then a continuous intravenous infusion at a rate of 1 g h-1. The control group received the same volume of physiological saline. Neuromuscular function was evaluated continuously in both groups. MAIN OUTCOME MEASURES Total recovery time was the primary outcome. Onset time, clinical duration, recovery index and recovery time were considered as secondary endpoints. Values are given as mean [SD]. RESULTS Total recovery time from neuromuscular block (NMB) was 113 [36] min in the magnesium group and 101 [39] min in the control group. Clinical duration was 69 [23] min in the magnesium group and 59 [28] min in the control group. Recovery index was 19 [36] min in the magnesium group and 17 [6] min in the control group. Recovery timewas 44 [22] min in the magnesium group and 42 [18] min in the control group. There were no statistically significant differences between the groups in any of the recovery indices. In the magnesium group, the mean onset time was 144 [58] s, significantly shorter than the onset time in the group that received physiological saline, which was 187 [90] s (P-0.03). Group variances were compared using an F test: onset time varied significantly less in the magnesium group (P-0.02). CONCLUSION In oncology patients of 60 or more years of age, preadministration of MgSO4, with the doses used in this study, significantly reduced the onset time of NMB induced by rocuronium. © 2013 European Society of Anaesthesiology.en
dc.description.affiliationSurgical Science Postgraduate Program Department of Surgery Universidade Federal Do Rio de Janeiro, Praça Cruz Vermelha, 23 Centro, Rio de Janeiro CEP: 20230-130
dc.description.affiliationDepartment of General and Specialised Surgery Universidade Federal Fluminense, Niterói
dc.description.affiliationUniversidade Federal Do Rio de Janeiro
dc.description.affiliationDepartment of Anesthesiology Universidade Estadual Paulista, Botucatu, São Paulo
dc.description.affiliationDepartment of Surgery Universidade Federal Do Rio de Janeiro, Rio de Janeiro
dc.description.affiliationUnespDepartment of Anesthesiology Universidade Estadual Paulista, Botucatu, São Paulo
dc.format.extent599-604
dc.identifierhttp://dx.doi.org/10.1097/EJA.0b013e328361d342
dc.identifier.citationEuropean Journal of Anaesthesiology, v. 30, n. 10, p. 599-604, 2013.
dc.identifier.doi10.1097/EJA.0b013e328361d342
dc.identifier.issn0265-0215
dc.identifier.issn1365-2346
dc.identifier.lattes7802830125342070
dc.identifier.scopus2-s2.0-84884485238
dc.identifier.urihttp://hdl.handle.net/11449/76742
dc.identifier.wosWOS:000326729800005
dc.language.isoeng
dc.relation.ispartofEuropean Journal of Anaesthesiology
dc.relation.ispartofjcr3.958
dc.relation.ispartofsjr1,179
dc.relation.ispartofsjr1,179
dc.rights.accessRightsAcesso restrito
dc.sourceScopus
dc.subjectmagnesium sulfate
dc.subjectrocuronium
dc.subjectsodium chloride
dc.subjectadult
dc.subjectaged
dc.subjectburning sensation
dc.subjectcontrolled study
dc.subjectdouble blind procedure
dc.subjectdrug effect
dc.subjectfemale
dc.subjecthead and neck surgery
dc.subjecthuman
dc.subjectmajor clinical study
dc.subjectmale
dc.subjectneuromuscular blocking
dc.subjectneuromuscular function
dc.subjectoutcome assessment
dc.subjectprospective study
dc.subjectrandomized controlled trial
dc.titleEffects of magnesium sulphate on the pharmacodynamics of rocuronium in patients aged 60 years and older: A randomised trialen
dc.typeArtigo
dcterms.licensehttp://edmgr.ovid.com/spine/accounts/copyrightTransfer.pdf
unesp.author.lattes7802830125342070
unesp.campusUniversidade Estadual Paulista (Unesp), Faculdade de Medicina, Botucatupt

Arquivos